(7) Further studies could consider obtaining data on RNA sequencing, proteomics, lipidomics, or metabolomics to provide valuable insights into the molecular state of patients with HR+/HER2− breast cancer and contribute to the research progression of this cancer. This evidence concerns the gene HR and breast carcinoma.